Implantable device may reverse type 2 diabetes

08/7/2011 | Daily Mail (London), The

The EndoBarrier, a newly developed implantable sleeve, resulted in remission of type 2 diabetes in 72% of obese patients, experts at U.K.-based Musgrove Park Hospital found. The device, an incisionless alternative to duodenum switch, lines the duodenum and only allows food absorption into the lower parts of the small intestine.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI